| Literature DB >> 27848183 |
Keita Tamaki1, Satoko Morishima2, Sawako Nakachi1, Sakiko Kitamura1, Sachie Uchibori1, Shouhei Tomori1, Taeko Hanashiro1, Natsuki Shimabukuro1, Iori Tedokon1, Kazuho Morichika1, Yukiko Nishi1, Takeaki Tomoyose3, Kennosuke Karube4, Takuya Fukushima5, Hiroaki Masuzaki6.
Abstract
Here, we report a rare case of systemic lupus erythematosus (SLE) with conspicuous manifestation of hematological abnormalities. At onset, the 52-year-old male patient showed systemic lymphadenopathy and splenomegaly, severe autoimmune thrombocytopenia, and autoimmune neutropenia. Bone marrow examination and lymph node biopsy excluded the possibility of malignant lymphoma. Based on laboratory findings, he was finally diagnosed with combined autoimmune cytopenia coupled with SLE. Atypical clinical manifestations of SLE prompted us to explore the possibility of autoimmune lymphoproliferative syndrome (ALPS). However, we did not detect an increased number of CD4-/CD8-, CD3+, TCRαβ+ double-negative T cells in the circulating blood or dysfunctional T cell apoptosis in the Fas/Fas ligand pathway due to mutations in the FAS, FASLG or CASP10 genes. Combined autoimmune cytopenia is a rare clinical entity that in some cases co-occurs with other autoimmune diseases. Given that most SLE patients presenting atypical hematological manifestations at an early stage subsequently exhibit typical systemic manifestations, the present case raises the possibility that initial hematological abnormalities may be signs of unexpected SLE manifestations.Entities:
Keywords: Autoimmune lymphoproliferative syndrome (ALPS); Malignant lymphoma; Severe autoimmune neutropenia (AIN); Severe autoimmune thrombocytopenia (ITP); Systemic lupus erythematosus (SLE); Systemic lymphadenopathy
Mesh:
Year: 2016 PMID: 27848183 DOI: 10.1007/s12185-016-2126-8
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490